Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.100
+0.290 (7.61%)
At close: Feb 6, 2026, 4:00 PM EST
4.250
+0.150 (3.66%)
After-hours: Feb 6, 2026, 7:58 PM EST
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $366.33 million as of February 6, 2026. Its market cap has decreased by -57.65% in one year.
Market Cap
366.33M
Enterprise Value
263.75M
1-Year Change
-57.65%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $366.33M, an increase of 28.72%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 366.30M | 15.15% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 367.29M |
| Allogene Therapeutics | 366.31M |
| Entrada Therapeutics | 360.41M |
| Autolus Therapeutics | 351.31M |
| Greenwich LifeSciences | 349.00M |
| Protara Therapeutics | 348.32M |
| Puma Biotechnology | 342.16M |
| Aura Biosciences | 340.38M |